Skip to content

Comparative study of the effect of capsules "Ginger-Lavender", "Ginger" with "Mefenamic Acid " on the severity of primary dysmenorrhea

Comparative study of the effect of capsules "Ginger-Lavender" ,"Ginger" with "Mefenamic Acid " on the severity of primary dysmenorrhea

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200525047565N2
Enrollment
90
Registered
2021-01-03
Start date
2020-08-09
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea. Primary dysmenorrhoea

Interventions

Intervention 1: Intervention group: "Ginger-Lavender" group500 mg capsules containing 250 mg of ginger and 250 mg of lavender prepared in Shahid Beheshti School of Traditional Medicine will be used 4

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1)Be 18 to 30 years old and single. 2)Experience menstrual pain in the first 3 days of bleeding for 3 consecutive periods in the last 6 months 3)People with primary dysmenorrhea whose pain intensity is moderate to severe according to McGill's pain ruler 4)Not known to be a person with a chronic illness (diabetes, high blood pressure, cardiovascular, infectious, liver, and epilepsy) 5)Do not have a specific gynecological disease that interferes with the study process 6)Have regular cycles with intervals of 21 to 38 days and the duration of menstruation is 3-7 days 7)Their body mass index is in the normal range of 19.8 to 26 8)According to the person, there are no symptoms such as burning, itching or abnormal discharge during the study. 9)Do not take any medications or supplements. 10)No herbal medicine has been used for 3 months before the intervention.01 11)Stressful factors such as parental separation, death of first-degree relatives, etc. should not be present in the last six months

Exclusion criteria

Exclusion criteria: 1)Dissatisfaction or obedience of the person to continue participating in the study 2)Lack of proper use of medication or mefenamic acid 3)Take any herbal medicine while studying

Design outcomes

Primary

MeasureTime frame
Severity of primary dysmenorrhea. Timepoint: End of the third day of the cycle before the intervention, end of the third day of the first cycle and second cycle after the intervention. Method of measurement: Visual analog scale.

Secondary

MeasureTime frame
Systematic symptoms. Timepoint: End of the third day of the cycle before the intervention, end of the third day of the first cycle and second cycle after the intervention. Method of measurement: Verbal rating scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSharareh Jannesari

Shahid Beheshti University of Medical Sciences

shararehjannesari@gmail.com+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026